{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T23:53:03Z","timestamp":1775778783079,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,7]],"date-time":"2021-11-07T00:00:00Z","timestamp":1636243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,7]],"date-time":"2021-11-07T00:00:00Z","timestamp":1636243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Polycystic ovary syndrome (PCOS) is a common reproductive endocrine disease in women. Insulin resistance (IR) has emerged as a central contributor to the pathogenesis of this disease. According to traditional Chinese medicine (TCM), kidney deficiency is the main syndrome of PCOS. The deficiency of the kidney cannot vaporize water-dampness, and the retention of water-dampness accumulates into phlegm dampness stagnation, resulting in visceral dysfunction and metabolic disorder. TCM involving syndrome differentiation and treatment is widely used to adjust women\u2019s menstrual cycles. Our patented formula Bushen Huatan Decoction (BSHTD) has been proven to be effective in the clinical treatment of IR-PCOS. Baduanjin also plays an important role in improving metabolic syndrome through lifestyle intervention. This study investigates the clinical efficacy of Bushen Huatan Decoction combined with Baduanjin in IR-PCOS, to form a specific TCM-behaviour intervention plan in the treatment of IR-PCOS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods\/design<\/jats:title>\n                <jats:p>This is a randomized controlled trial involving 190 participants diagnosed with IR-PCOS. All participants will be randomly allocated into 5 groups: group A will receive metformin; group B, BSHTD; group C, Baduanjin; group D, BSHTD combined with metformin; and group E, BSHTD combined with Baduanjin. One course of treatment lasts 3 months, a total of two courses. The primary outcomes are changes in the homeostatic model assessment of insulin resistance (HOMA-IR) and improvements in the oral glucose tolerance test (OGTT) and insulin-releasing test (INS). The secondary outcomes are improvements in the menstrual cycle, ovulation rate, clinical pregnancy rate, basic serum sex hormone levels, free androgen index (FAI), Ferriman-Gallwey scores, body mass index (BMI) and TCM syndrome scores. The related observation indexes will be collected at baseline, during the process of treatment and at the 6-month follow-up. Simultaneously, close monitoring of possible adverse events will be performed throughout the trial process.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This trial will investigate the efficacy of the comprehensive intervention program of Bushen Huatan Decoction combined with Baduanjin on the adjustment of the menstrual cycle, improvement of insulin resistance and correction of glucose metabolism disorder in IR-PCOS patients. It is expected to form an alternative treatment of TCM-behaviour intervention therapy for IR-PCOS and promote the Chinese fitness Qigong Baduanjin in the application of lifestyle diseases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Chinese Clinical Trial Registry <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.chictr.org.cn\/showproj.aspx?proj=62706\">ChiCTR2100043415<\/jats:ext-link>. Registered on 15 February 2021.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-021-05770-z","type":"journal-article","created":{"date-parts":[[2021,11,7]],"date-time":"2021-11-07T21:02:26Z","timestamp":1636318946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy of Bushen Huatan Decoction combined with Baduanjin in the treatment of polycystic ovary syndrome with insulin resistance (IR-PCOS), kidney deficiency and phlegm dampness: study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7446-7151","authenticated-orcid":false,"given":"Haiqing","family":"Qian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9222-1473","authenticated-orcid":false,"given":"Wenting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2523-800X","authenticated-orcid":false,"given":"Lijuan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3216-8292","authenticated-orcid":false,"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6471-0798","authenticated-orcid":false,"given":"Jiahui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9810-7142","authenticated-orcid":false,"given":"Mengyu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1714-6650","authenticated-orcid":false,"given":"Minggang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7187-5910","authenticated-orcid":false,"given":"Lihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,7]]},"reference":[{"issue":"5","key":"5770_CR1","doi-asserted-by":"publisher","first-page":"CD010287","DOI":"10.1002\/14651858.CD010287","volume":"5","author":"S Franik","year":"2018","unstructured":"Franik S, Eltrop SM, Kremer JA, Kiesel L, Farquhar C. Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2018;5(5):CD010287. Published 2018 May 24. https:\/\/doi.org\/10.1002\/14651858.CD010287.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"5770_CR2","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/humupd\/dmw025","volume":"22","author":"AH Balen","year":"2016","unstructured":"Balen AH, Morley LC, Misso M, Franks S, Legro RS, Wijeyaratne CN, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016;22(6):687\u2013708. https:\/\/doi.org\/10.1093\/humupd\/dmw025.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"5770_CR3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1210\/jc.2014-2419","volume":"100","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Zhang C, Huang Y, Yu Y, Li R, Li M, et al. Up-regulated expression of WNT5a increases inflammation and oxidative stress via PI3K\/AKT\/NF-\u03baB signaling in the granulosa cells of PCOS patients. J Clin Endocrinol Metab. 2015;100(1):201\u201311. https:\/\/doi.org\/10.1210\/jc.2014-2419.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"5770_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270\u201384. https:\/\/doi.org\/10.1038\/nrendo.2018.24.","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"5770_CR5","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981\u20131030. https:\/\/doi.org\/10.1210\/er.2011-1034.","journal-title":"Endocr Rev"},{"issue":"2","key":"5770_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","volume":"132","author":"R Azziz","year":"2018","unstructured":"Azziz R. Polycystic Ovary Syndrome. Obstet Gynecol. 2018;132(2):321\u201336. https:\/\/doi.org\/10.1097\/AOG.0000000000002698.","journal-title":"Obstet Gynecol"},{"issue":"12","key":"5770_CR7","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.4158\/EP15748.DSCPT2","volume":"21","author":"NF Goodman","year":"2015","unstructured":"Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome - Part 2. Endocr Pract. 2015;21(12):1415\u201326. https:\/\/doi.org\/10.4158\/EP15748.DSCPT2.","journal-title":"Endocr Pract"},{"issue":"4","key":"5770_CR8","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1089\/acm.2017.0241","volume":"24","author":"L Zou","year":"2018","unstructured":"Zou L, Pan Z, Yeung A, Talwar S, Wang C, Liu Y, et al. A review study on the beneficial effects of Baduanjin. J Altern Complement Med. 2018;24(4):324\u201335. https:\/\/doi.org\/10.1089\/acm.2017.0241.","journal-title":"J Altern Complement Med"},{"issue":"2","key":"5770_CR9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s11655-015-2147-9","volume":"22","author":"LH Wang","year":"2016","unstructured":"Wang LH, Wang X, Yu XZ, Xu WT. Potent therapeutic effects of Shouwu Jiangqi Decoction on polycystic ovary syndrome with insulin resistance in rats. Chin J Integr Med. 2016;22(2):116\u201323. https:\/\/doi.org\/10.1007\/s11655-015-2147-9.","journal-title":"Chin J Integr Med"},{"key":"5770_CR10","doi-asserted-by":"publisher","first-page":"104544","DOI":"10.1016\/j.yrtph.2019.104544","volume":"110","author":"N Zhang","year":"2020","unstructured":"Zhang N, Liu X, Zhuang L, Liu X, Zhao H, Shan Y, et al. Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: dual regulation of the PI3K\/AKT and MAPK pathways. Regul Toxicol Pharmacol. 2020;110:104544. https:\/\/doi.org\/10.1016\/j.yrtph.2019.104544.","journal-title":"Regul Toxicol Pharmacol"},{"issue":"4","key":"5770_CR11","doi-asserted-by":"publisher","first-page":"290","DOI":"10.7326\/0003-4819-154-4-201102150-00016","volume":"154","author":"ZX Bian","year":"2011","unstructured":"Bian ZX, Shang HC. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2011;154(4):290\u20132. https:\/\/doi.org\/10.7326\/0003-4819-154-4-201102150-00016.","journal-title":"Ann Intern Med"},{"issue":"3","key":"5770_CR12","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200\u20137. https:\/\/doi.org\/10.7326\/0003-4819-158-3-201302050-00583.","journal-title":"Ann Intern Med"},{"issue":"2","key":"5770_CR13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/humrep\/dew329","volume":"32","author":"MM Ollila","year":"2017","unstructured":"Ollila MM, West S, Kein\u00e4nen-Kiukaanniemi S, et al. Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study. Hum Reprod. 2017;32(2):423\u201331. https:\/\/doi.org\/10.1093\/humrep\/dew329.","journal-title":"Hum Reprod"},{"issue":"1","key":"5770_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41\u20137. https:\/\/doi.org\/10.1093\/humrep\/deh098.","journal-title":"Hum Reprod"},{"issue":"3","key":"5770_CR15","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.fertnstert.2011.06.040","volume":"96","author":"X Zhao","year":"2011","unstructured":"Zhao X, Ni R, Li L, Mo Y, Huang J, Huang M, et al. Defining hirsutism in Chinese women: a cross-sectional study. Fertil Steril. 2011;96(3):792\u20136. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.06.040.","journal-title":"Fertil Steril"},{"issue":"11","key":"5770_CR16","doi-asserted-by":"publisher","first-page":"e0165033","DOI":"10.1371\/journal.pone.0165033","volume":"11","author":"NM Daan","year":"2016","unstructured":"Daan NM, Koster MP, de Wilde MA, et al. Biomarker profiles in women with PCOS and PCOS offspring; a pilot study. PLoS One. 2016;11(11):e0165033. Published 2016 Nov 2. https:\/\/doi.org\/10.1371\/journal.pone.0165033.","journal-title":"PLoS One"},{"key":"5770_CR17","doi-asserted-by":"publisher","unstructured":"Chen C, Jing G, Li Z, Juan S, Bin C, Jie H. Insulin resistance and polycystic ovary syndrome in a Chinese population. Endocr Pract. 2017:10.4158\/EP171849.OR. https:\/\/doi.org\/10.4158\/EP171849.OR.","DOI":"10.4158\/EP171849.OR"},{"issue":"5","key":"5770_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.7748\/nr.23.5.21.s5","volume":"23","author":"HE Malone","year":"2016","unstructured":"Malone HE, Nicholl H, Coyne I. Fundamentals of estimating sample size. Nurs Res. 2016;23(5):21\u20135. https:\/\/doi.org\/10.7748\/nr.23.5.21.s5.","journal-title":"Nurs Res"},{"issue":"1","key":"5770_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13063-020-4060-6","volume":"21","author":"CM Ni","year":"2020","unstructured":"Ni CM, Huang WL, Jiang YM, et al. Improving the accuracy and efficacy of diagnosing polycystic ovary syndrome by integrating metabolomics with clinical characteristics: study protocol for a randomized controlled trial. Trials. 2020;21(1):169. Published 2020 Feb 11. https:\/\/doi.org\/10.1186\/s13063-020-4060-6.","journal-title":"Trials"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05770-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-021-05770-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05770-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,7]],"date-time":"2021-11-07T21:09:32Z","timestamp":1636319372000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-021-05770-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,7]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5770"],"URL":"https:\/\/doi.org\/10.1186\/s13063-021-05770-z","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,7]]},"assertion":[{"value":"7 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This trial has been approved by the ethics committee of Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine. This trial has been registered at the Chinese Clinical Trial Registry (ChiCTR2100043415). Written informed consent will be obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"781"}}